BSND
Barttin
Also known as: BART, BSND_HUMAN, DFNB73
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8WZ55
- Gene
- BSND
- Ensembl
- ENSG00000162399
- Chromosome
- 1
- Canonical length
- 320 aa
- Protein class
- Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters
OverviewNCBI Gene
This gene encodes an essential beta subunit for CLC chloride channels. These heteromeric channels localize to basolateral membranes of renal tubules and of potassium-secreting epithelia of the inner ear. Mutations in this gene have been associated with Bartter syndrome with sensorineural deafness. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
320 residues, UniProt reviewed canonical sequence.
>Q8WZ55|BSND
1 MADEKTFRIG FIVLGLFLLA LGTFLMSHDR PQVYGTFYAM GSVMVIGGII WSMCQCYPKI
61 TFVPADSDFQ GILSPKAMGL LENGLAAEMK SPSPQPPYVR LWEEAAYDQS LPDFSHIQMK
121 VMSYSEDHRS LLAPEMGQPK LGTSDGGEGG PGDVQAWMEA AVVIHKGSDE SEGERRLTQS
181 WPGPLACPQG PAPLASFQDD LDMDSSEGSS PNASPHDREE ACSPQQEPQG CRCPLDRFQD
241 FALIDAPTLE DEPQEGQQWE IALPNNWQRY PRTKVEEKEA SDTGGEEPEK EEEDLYYGLP
301 DGAGDLLPDK ELGFEPDTQGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against BSND can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 2
- Mean surface accessibility (rSASA)
- 0.68
- Highest tissue expression
- 3.8 nTPM
Expression across tissuesHPA
Tissue
- kidney: 3.8 nTPM
- salivary gland: 1.4 nTPM
- pituitary gland: 0.4 nTPM
- cerebellum: 0.2 nTPM
- testis: 0.1 nTPM
- adipose tissue: 0 nTPM
Single-cell type
- respiratory ionocytes: 112 nCPM
- salivary ionocytes: 70 nCPM
- epididymal clear cells: 39 nCPM
- renal collecting duct intercalated cells: 21 nCPM
- loop of henle epithelial cells: 15 nCPM
- epicardial cells: 11 nCPM
Immune cell
- neutrophil: 0.6 nTPM
- basophil: 0.4 nTPM
- classical monocyte: 0.1 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- cerebellum: 2 nTPM
- cerebral cortex: 1.1 nTPM
- pons: 1.1 nTPM
- amygdala: 1 nTPM
- basal ganglia: 1 nTPM
- hippocampal formation: 1 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about BSND.
Disease | AllUniProt
Conditions BSND is implicated in, by any mechanism.
- Bartter syndrome 4A, neonatal, with sensorineural deafness (BARTS4A) MIM:602522
Disease | GeneticClinVar
39 pathogenic / likely-pathogenic of 414 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Bartter syndrome
- Bartter disease type 4A
- Hearing loss, autosomal recessive
- Sensorineural deafness with mild renal dysfunction
- BSND-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.78
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.07
- DepMap mean gene effect
- -0.1
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Barttin
- Bartter syndrome, infantile, with sensorineural deafness (Barttin)
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of BSND in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads BSND as an antibody target. Whether an autoantibody or antibody against BSND could matter depends on whether native BSND is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
BSND is annotated at the cell surface, where native BSND is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label BSND as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...